​

UnitedHealth Group (UNH) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

UNH Stock Forecast

UnitedHealth Group (UNH) stock forecast, based on 51 Wall Street analysts, predicts a 12-month average price target of $387.80, with a high of $440.00 and a low of $198.00. This represents a 15.17% increase from the last price of $336.71.

$150 $250 $350 $450 $550 $650 High: $440 Avg: $387.8 Low: $198 Last Closed Price: $336.71

UNH Stock Rating

UnitedHealth Group stock's rating consensus is Buy, based on 51 Wall Street analysts. The breakdown includes 1 Strong Buy (1.96%), 39 Buy (76.47%), 7 Hold (13.73%), 4 Sell (7.84%), and 0 Strong Sell (0.00%).

Buy
Total 51 4 7 39 1 Strong Sell Sell Hold Buy Strong Buy

UNH Price Target Upside V Benchmarks

TypeNameUpside
StockUnitedHealth Group15.17%
SectorHealthcare Stocks 15.45%
IndustryHealthcare Plans Stocks14.06%

Price Target Trends

1M3M12M
# Anlaysts-1531
Avg Price Target-$408.47$387.39
Last Closing Price$336.71$336.71$336.71
Upside/Downside-21.31%15.05%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Dec, 2561262-26
Nov, 2551372-27
Oct, 2551362-26
Sep, 2561352-26
Aug, 2561352-26
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 30, 2025Bernstein$440.00$355.2623.85%30.68%
Oct 29, 2025UBS$430.00$361.9618.80%27.71%
Oct 29, 2025Ben HendrixRBC Capital$408.00$361.9612.72%21.17%
Oct 29, 2025Oppenheimer$415.00$367.8412.82%23.25%
Oct 29, 2025Whit MayoLeerink Partners$410.00$367.8411.46%21.77%
Oct 29, 2025Deutsche Bank$333.00$367.84-9.47%-1.10%
Oct 28, 2025Jessica TassanPiper Sandler$417.00$367.8113.37%23.85%
Oct 17, 2025David WindleyJefferies$409.00$356.6714.67%21.47%
Oct 14, 2025Truist Financial$410.00$357.5514.67%21.77%
Oct 14, 2025Goldman Sachs$406.00$358.6613.20%20.58%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 30, 2025Cowen & Co.HoldHoldhold
Oct 30, 2025BernsteinOutperformOutperformhold
Oct 29, 2025UBSBuyBuyhold
Oct 29, 2025RBC CapitalOutperformOutperformhold
Oct 29, 2025OppenheimerOutperformOutperformhold
Oct 29, 2025Deutsche BankBuyHolddowngrade
Oct 29, 2025Leerink PartnersOutperformOutperformhold
Oct 28, 2025Piper SandlerOverweightOverweighthold
Oct 17, 2025JefferiesBuyBuyhold
Oct 14, 2025Goldman SachsBuyBuyinitialise

Financial Forecast

EPS Forecast

$15 $23 $31 $39 $47 $55 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$16.28$18.33$21.54$24.12$15.51-----
Avg Forecast$16.74$18.84$22.02$24.96$27.61$29.72$33.50$38.08$43.85$50.63
High Forecast$17.04$19.18$22.77$25.02$27.79$30.08$34.27$39.69$44.83$51.76
Low Forecast$16.40$18.46$21.33$24.87$27.30$28.45$32.22$35.72$42.05$48.55
Surprise %-2.75%-2.71%-2.18%-3.37%-43.82%-----

Revenue Forecast

$250B $340B $430B $520B $610B $700B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$255.64B$285.27B$322.13B$367.53B$400.28B-----
Avg Forecast$256.44B$286.74B$323.88B$369.14B$400.99B$450.84B$486.57B$522.61B$589.76B$675.82B
High Forecast$260.00B$290.73B$332.33B$370.46B$402.87B$453.61B$497.97B$523.71B$599.90B$687.44B
Low Forecast$252.46B$282.29B$316.03B$367.79B$400.03B$441.53B$469.85B$521.51B$571.09B$654.43B
Surprise %-0.31%-0.51%-0.54%-0.44%-0.18%-----

Net Income Forecast

$5B $14B $23B $32B $41B $50B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$15.40B$17.29B$20.12B$22.38B$14.40B-----
Avg Forecast$12.47B$15.70B$17.98B$22.38B$25.59B$27.19B$30.89B$35.03B$40.74B$47.04B
High Forecast$14.97B$18.84B$21.58B$26.86B$25.81B$27.95B$31.83B$36.87B$41.65B$48.09B
Low Forecast$9.98B$12.56B$14.39B$17.90B$25.36B$26.43B$29.94B$33.18B$39.06B$45.10B
Surprise %23.48%10.10%11.89%--43.70%-----

UNH Forecast FAQ

Is UnitedHealth Group stock a buy?

UnitedHealth Group stock has a consensus rating of Buy, based on 51 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 39 Buy, 7 Hold, 4 Sell, and 0 Strong Sell, reflecting a consensus that UnitedHealth Group is a favorable investment for most analysts.

What is UnitedHealth Group's price target?

UnitedHealth Group's price target, set by 51 Wall Street analysts, averages $387.8 over the next 12 months. The price target range spans from $198 at the low end to $440 at the high end, suggesting a potential 15.17% change from the previous closing price of $336.71.

How does UnitedHealth Group stock forecast compare to its benchmarks?

UnitedHealth Group's stock forecast shows a 15.17% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the healthcare plans stocks industry (14.06%).

What is the breakdown of analyst ratings for UnitedHealth Group over the past three months?

  • December 2025: 23.08% Strong Buy, 46.15% Buy, 23.08% Hold, 7.69% Sell, 0% Strong Sell.
  • November 2025: 18.52% Strong Buy, 48.15% Buy, 25.93% Hold, 7.41% Sell, 0% Strong Sell.
  • October 2025: 19.23% Strong Buy, 50.00% Buy, 23.08% Hold, 7.69% Sell, 0% Strong Sell.

What is UnitedHealth Group’s EPS forecast?

UnitedHealth Group's average annual EPS forecast for its fiscal year ending in December 2025 is $29.72, marking a 91.62% increase from the reported $15.51 in 2024. Estimates for the following years are $33.5 in 2026, $38.08 in 2027, $43.85 in 2028, and $50.63 in 2029.

What is UnitedHealth Group’s revenue forecast?

UnitedHealth Group's average annual revenue forecast for its fiscal year ending in December 2025 is $450.84B, reflecting a 12.63% increase from the reported $400.28B in 2024. The forecast for 2026 is $486.57B, followed by $522.61B for 2027, $589.76B for 2028, and $675.82B for 2029.

What is UnitedHealth Group’s net income forecast?

UnitedHealth Group's net income forecast for the fiscal year ending in December 2025 stands at $27.19B, representing an 88.73% increase from the reported $14.4B in 2024. Projections indicate $30.89B in 2026, $35.03B in 2027, $40.74B in 2028, and $47.04B in 2029.